Markets
Trump wins election
(Kent Nishimura/Getty Images)

The market’s verdict on Trump 2.0

It’s a pretty big deal.

Where should we start? Don’t know if you happened to watch the news last night, but Republican Donald J. Trump won the 2024 election, defeating Democrat Kamala Harris in a close, but decisive, election.

Because of the fact that polls had shown an incredibly tight race, Trump’s victory was indeed new and important information for markets and investors.

There’s really no end to the potential implications for investors.

Trump has threatened to impose across-the-board tariffs, and even the Trump-friendly Wall Street Journal has said his second term in office could “radically remake world trade.” And his personal and political record indicates that government deficits, already immense, may get much larger with him in office, which could both supercharge already solid economic growth, or potentially reignite inflation. Maybe both. Nobody knows exactly.

There’s a lot of uncertainty out there, but there are also plenty of big, interesting moves afoot in financial markets. Here are some of the most notable and how we, and others, are making sense of them.

The dollar got a lot stronger

The greenback — as measured by the US dollar index — soared overnight and is currently on track for its biggest single-day gain since September 2016.

Why? Remember, currency prices are always measured against other currencies. The strength of the US dollar actually reflects a sharp weakening of currencies of major trading partners, including longtime allies like the UK and the EU. In theory, the US dollar can serve as a “release valve” to offset the impact of potential tariffs: the cost of a foreign good doesn’t go up as much for a domestic importer if the US dollar rises relative to that foreign currency.

Interest rates jumped

Yields on the benchmark US 10-year Treasury note jumped on the election news, rising about 0.15 percentage points, the most since April.

Why? Tread carefully when trying to explain bond-market moves. Long-term bond yields are traditionally sensitive to changes in the outlook for inflation and economic growth. So, you could read this as indicating an uptick in either of those, or both, under the Trump administration. When we decompose the move in Treasuries into the so-called breakeven inflation component and real rate component, it looks like a mix of both.

This also likely reflects some relief from investors that the election is over, so people are moving from the safety of bonds to riskier stuff like stocks. (Remember, bond prices and bond yields move in opposite directions, so when bond yields rise, it means the price of those bonds is going down.)

As a side note, this is going to feed through to higher mortgage rates, which won’t help housing affordability at all in the short term.

Stocks hit a record high

The market posted a pretty solid gain after the vote came in, rising about 2% and putting the S&P 500 on track for its biggest gain since early August. The Russell 2000 index of small-cap stocks exploded, rising more than 5%. The Nasdaq 100 rose about 2%.

Why? Again, it’s worth being careful about attributing the move to any one thing. But clearly some investors could see the potential merits of the Trump-related reduction in regulation — credit-card stocks such as Synchrony Financial and Discoverposted explosive gains, for instance. Also, the Russell 2000’s gains likely reflect expectations for a potential enhancement of Trump’s corporate tax cuts under what looks to be unified Republican control in Washington. Small caps tend to be more domestically focused. That makes them more sensitive to US tax rates as they’re unable to use a global footprint to minimize tax exposure the way corporate giants in the S&P 500 can.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets
Luke Kawa

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.